| Product Code: ETC12568674 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of long-acting insulin to Finland show a steady growth trend, with key exporting countries being Germany, Netherlands, Denmark, Sweden, and the USA. The market concentration, as measured by the HHI, has improved from very low to low concentration levels between 2023 and 2024. The compound annual growth rate (CAGR) from 2020 to 2024 stands at 2.88%, indicating a consistent increase in imports. Additionally, the growth rate from 2023 to 2024 is 0.14%, suggesting a slight acceleration in the market. This data highlights a positive outlook for the long-acting insulin market in Finland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Long Acting Insulin Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Long Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Long Acting Insulin Market - Industry Life Cycle |
3.4 Finland Long Acting Insulin Market - Porter's Five Forces |
3.5 Finland Long Acting Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Finland Long Acting Insulin Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Finland Long Acting Insulin Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 Finland Long Acting Insulin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Finland Long Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Finland |
4.2.2 Growing awareness about the benefits of long-acting insulin in managing diabetes |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of long-acting insulin products |
4.3.2 Competition from alternative diabetes management therapies |
4.3.3 High cost associated with long-acting insulin treatments |
5 Finland Long Acting Insulin Market Trends |
6 Finland Long Acting Insulin Market, By Types |
6.1 Finland Long Acting Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Long Acting Insulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Finland Long Acting Insulin Market Revenues & Volume, By Lantus, 2021 - 2031F |
6.1.4 Finland Long Acting Insulin Market Revenues & Volume, By Levemir, 2021 - 2031F |
6.1.5 Finland Long Acting Insulin Market Revenues & Volume, By Tresiba, 2021 - 2031F |
6.1.6 Finland Long Acting Insulin Market Revenues & Volume, By Basaglar, 2021 - 2031F |
6.1.7 Finland Long Acting Insulin Market Revenues & Volume, By Toujeo, 2021 - 2031F |
6.2 Finland Long Acting Insulin Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Finland Long Acting Insulin Market Revenues & Volume, By Pen, 2021 - 2031F |
6.2.3 Finland Long Acting Insulin Market Revenues & Volume, By Syringe, 2021 - 2031F |
6.2.4 Finland Long Acting Insulin Market Revenues & Volume, By Pump, 2021 - 2031F |
6.2.5 Finland Long Acting Insulin Market Revenues & Volume, By Pre-filled Device, 2021 - 2031F |
6.3 Finland Long Acting Insulin Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Finland Long Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.3.3 Finland Long Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Finland Long Acting Insulin Market Revenues & Volume, By Gestational Diabetes, 2021 - 2031F |
6.4 Finland Long Acting Insulin Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Finland Long Acting Insulin Market Revenues & Volume, By Solution, 2021 - 2031F |
6.4.3 Finland Long Acting Insulin Market Revenues & Volume, By Suspension, 2021 - 2031F |
7 Finland Long Acting Insulin Market Import-Export Trade Statistics |
7.1 Finland Long Acting Insulin Market Export to Major Countries |
7.2 Finland Long Acting Insulin Market Imports from Major Countries |
8 Finland Long Acting Insulin Market Key Performance Indicators |
8.1 Patient adherence rate to long-acting insulin therapy |
8.2 Rate of adoption of new long-acting insulin products in the market |
8.3 Number of clinical trials and research studies conducted on long-acting insulin efficacy and safety |
8.4 Average time to market for new long-acting insulin products |
8.5 Patient satisfaction and feedback on long-acting insulin products |
9 Finland Long Acting Insulin Market - Opportunity Assessment |
9.1 Finland Long Acting Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Finland Long Acting Insulin Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Finland Long Acting Insulin Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 Finland Long Acting Insulin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Finland Long Acting Insulin Market - Competitive Landscape |
10.1 Finland Long Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Finland Long Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here